OTC Drugs-Of-Abuse Assay Firms Should Provide Confirmatory Testing - Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA should require manufacturers of over-the-counter (OTC) screening tests for drugs-of-abuse to cover the cost of confirmatory testing for presumptive positive results, members of FDA's Clinical Chemistry and Clinical Toxicology Devices panel recommended.